Title:
COMPOUNDS AS PARP1 INHIBITIORS
Document Type and Number:
WIPO Patent Application WO/2023/207283
Kind Code:
A1
Abstract:
Disclosed herein is the compounds and pharmaceutically acceptable salts thereof that inhibit the Poly (ADP-ribose) polymerase (PARP) family of enzymes. The present disclosure also relates to the use of these compounds or pharmaceutically acceptable salts thereof in the treatment of diseases.
Inventors:
WANG TINGZHONG (CN)
SHEN ZHENHAI (CN)
TALBOT ERIC P A (GB)
BATEMAN JOSEPH M (GB)
RAHEMTULLA BENJAMIN F (GB)
MOROGLU MUSTAFA (GB)
LADDUWAHETTY TAMMY (GB)
SHEN ZHENHAI (CN)
TALBOT ERIC P A (GB)
BATEMAN JOSEPH M (GB)
RAHEMTULLA BENJAMIN F (GB)
MOROGLU MUSTAFA (GB)
LADDUWAHETTY TAMMY (GB)
Application Number:
PCT/CN2023/077272
Publication Date:
November 02, 2023
Filing Date:
February 20, 2023
Export Citation:
Assignee:
NINGBO NEWBAY TECH DEVELOPMENT CO LTD (CN)
International Classes:
C07D471/04; A61K31/4375; A61P35/00; C07D401/14; C07D403/14
Domestic Patent References:
| WO2021013735A1 | 2021-01-28 |
Foreign References:
| US20120094992A1 | 2012-04-19 | |||
| CN101006078A | 2007-07-25 | |||
| US20100222348A1 | 2010-09-02 | |||
| CN1219930A | 1999-06-16 | |||
| US20060264429A1 | 2006-11-23 |
Attorney, Agent or Firm:
KING & WOOD MALLESONS (CN)
Download PDF: